Select for export Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms Details DOI 10.3929/ethz-c-000793359 Copy citation Copy BibTeX Repository for Publications and Research Data (ETH Zurich) 2026-01-19 Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Other Endocrinology More
Select for export FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD Details DOI 10.1016/s0168-8278(25)01632-0 Copy citation Copy BibTeX Journal of Hepatology 2025-04-30 Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other Psilocybin More
Select for export Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease Details DOI 10.1016/j.dld.2025.01.135 Copy citation Copy BibTeX Digestive and Liver Disease 2025-01-31 Martina Colognesi, Daniela Gabbia, A. Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut OpenAlex Published psilocybin Pharmacology Other Medicine More